Goldman Sachs’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.36M | Buy |
433,858
+166,454
| +62% | +$904K | ﹤0.01% | 3308 |
|
|
2025
Q1 | $741K | Sell |
267,404
-75,941
| -22% | -$210K | ﹤0.01% | 4018 |
|
|
2024
Q4 | $1.17M | Sell |
343,345
-29,573
| -8% | -$101K | ﹤0.01% | 3812 |
|
|
2024
Q3 | $1.1M | Sell |
372,918
-22,183
| -6% | -$65.2K | ﹤0.01% | 3702 |
|
|
2024
Q2 | $1.34M | Buy |
395,101
+71,266
| +22% | +$242K | ﹤0.01% | 3442 |
|
|
2024
Q1 | $981K | Sell |
323,835
-45,955
| -12% | -$139K | ﹤0.01% | 3632 |
|
|
2023
Q4 | $1.56M | Sell |
369,790
-146,212
| -28% | -$616K | ﹤0.01% | 3371 |
|
|
2023
Q3 | $3.52M | Buy |
516,002
+50,212
| +11% | +$343K | ﹤0.01% | 2728 |
|
|
2023
Q2 | $4.85M | Buy |
465,790
+1,149
| +0.2% | +$12K | ﹤0.01% | 2587 |
|
|
2023
Q1 | $3.24M | Buy |
464,641
+248,870
| +115% | +$1.73M | ﹤0.01% | 2868 |
|
|
2022
Q4 | $1.3M | Sell |
215,771
-171,205
| -44% | -$1.03M | ﹤0.01% | 3546 |
|
|
2022
Q3 | $3.05M | Sell |
386,976
-278,294
| -42% | -$2.19M | ﹤0.01% | 3033 |
|
|
2022
Q2 | $9.05M | Buy |
665,270
+384,046
| +137% | +$5.23M | ﹤0.01% | 2213 |
|
|
2022
Q1 | $5.52M | Sell |
281,224
-61,533
| -18% | -$1.21M | ﹤0.01% | 2721 |
|
|
2021
Q4 | $11.8M | Buy |
342,757
+225,397
| +192% | +$7.73M | ﹤0.01% | 2148 |
|
|
2021
Q3 | $6.41M | Buy |
117,360
+44,467
| +61% | +$2.43M | ﹤0.01% | 2613 |
|
|
2021
Q2 | $5.36M | Buy |
72,893
+56,017
| +332% | +$4.12M | ﹤0.01% | 2740 |
|
|
2021
Q1 | $1.54M | Buy |
16,876
+5,385
| +47% | +$492K | ﹤0.01% | 3599 |
|
|
2020
Q4 | $932K | Buy |
11,491
+4,570
| +66% | +$371K | ﹤0.01% | 3493 |
|
|
2020
Q3 | $322K | Buy |
+6,921
| New | +$322K | ﹤0.01% | 3868 |
|